Literature DB >> 8961753

Can fish oil maintain Crohn's disease in remission?

Y I Kim1.   

Abstract

One of the greatest challenges in managing Crohn's disease is to maintain remission. Although pharmacologic approaches to maintaining Crohn's disease in remission have significantly improved, most of the currently available modalities are associated with significant morbidity. Recently, an enteric-coated preparation of fish oil has been shown to be effective in reducing the rate of relapse in patients with Crohn's disease in remission who are at high risk of relapse. Because of minimal side effects, fish oil appears to be an ideal maintenance agent in Crohn's disease. However, until results from studies that compare the therapeutic effect of fish oil to the currently available maintenance agents are available, fish oil supplementation cannot be recommended as a sole maintenance agent at present. It does, however, seem prudent to promote a diet rich in fish oil in patients with Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961753     DOI: 10.1111/j.1753-4887.1996.tb03943.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  3 in total

1.  Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study.

Authors:  C Romano; S Cucchiara; A Barabino; V Annese; C Sferlazzas
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  The Effect of Omega-3 Fatty Acid Supplementation on the Inflammatory Response to eccentric strength exercise.

Authors:  Kelly B Jouris; Jennifer L McDaniel; Edward P Weiss
Journal:  J Sports Sci Med       Date:  2011-09-01       Impact factor: 2.988

Review 3.  Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease.

Authors:  Raffi Lev-Tzion; Anne Marie Griffiths; Oren Leder; Dan Turner
Journal:  Cochrane Database Syst Rev       Date:  2014-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.